C07K 14/745
Blood coagulation or fibrinolysis factors
C07K14/745 (Blood coagulation or fibrinolysis factors) appears on 1,809 US grants and 1,949 published applications in this corpus.
Search patents in C07K- Granted patents
- 1,809
- Published applications
- 1,949
- Assignees
- 913
- Inventors
- 3,533
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 4 | 0 |
| 1978 | 7 | 0 |
| 1979 | 5 | 0 |
| 1980 | 5 | 0 |
| 1981 | 10 | 0 |
| 1982 | 6 | 0 |
| 1983 | 10 | 0 |
| 1984 | 12 | 0 |
| 1985 | 8 | 0 |
| 1986 | 7 | 0 |
| 1987 | 19 | 0 |
| 1988 | 10 | 0 |
| 1989 | 16 | 0 |
| 1990 | 9 | 0 |
| 1991 | 18 | 0 |
| 1992 | 20 | 0 |
| 1993 | 32 | 0 |
| 1994 | 42 | 0 |
| 1995 | 35 | 0 |
| 1996 | 36 | 0 |
| 1997 | 70 | 0 |
| 1998 | 101 | 0 |
| 1999 | 73 | 0 |
| 2000 | 59 | 0 |
| 2001 | 51 | 8 |
| 2002 | 31 | 58 |
| 2003 | 27 | 79 |
| 2004 | 35 | 73 |
| 2005 | 29 | 57 |
| 2006 | 38 | 50 |
| 2007 | 28 | 52 |
| 2008 | 30 | 59 |
| 2009 | 40 | 67 |
| 2010 | 40 | 84 |
| 2011 | 52 | 67 |
| 2012 | 41 | 66 |
| 2013 | 46 | 98 |
| 2014 | 65 | 108 |
| 2015 | 65 | 102 |
| 2016 | 78 | 113 |
| 2017 | 54 | 85 |
| 2018 | 55 | 88 |
| 2019 | 56 | 101 |
| 2020 | 65 | 94 |
| 2021 | 74 | 86 |
| 2022 | 45 | 87 |
| 2023 | 39 | 72 |
| 2024 | 34 | 78 |
| 2025 | 47 | 70 |
| 2026 | 28 | 47 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Method for freezing cell structure25 Aug 2026US 12,714,096 B2Kyoto Prefectural Public University Corporation
- Regulation of von Willebrand factor (VWF)18 Aug 2026US 12,709,754 B2Band Therapeutics, LLC
- Recombinant proteins based on fibrinogen11 Aug 2026US 12,703,737 B2Sartorius Lab Instruments GmbH & Co. KG
- Methods and compositions for treating cancer with von Willebrand factor peptide linked to immunotherapeutic antibodies11 Aug 2026US 12,706,227 B2The University of Chicago
- Multi-chain chimeric polypeptides and uses thereof28 Jul 2026US 12,692,295 B2ImmunityBio, Inc.
- Extracellular Vesicles and Compositions Thereof1 Oct 2026US 2026/0294977 A1Exo Biologics SA
- Fviii fusion protein conjugate having extended half-life and use thereof17 Sep 2026US 2026/0274923 A1Jiangsu Gensciences Inc.
- Lentiviral System17 Sep 2026US 2026/0275376 A1Expression Therapeutics LLC
- Synthesis and structure of high potency rna therapeutics10 Sep 2026US 2026/0265769 A1Arcturus Therapeutics, Inc.
- Post-Natal Transplantation Of Factor VIII-Expressing Cells For Treatment of Hemophilia27 Aug 2026US 2026/0248857 A1Children's Healthcare of Atlanta, Inc.
Most cited
By later US patents
- Positive-negative selection methods and vectors410US 5,464,764 AUniversity of Utah Research Foundation · 1995
- Cells and non-human organisms containing predetermined genomic modifications and positive-negative selection methods and vectors for making same308US 5,487,992 AUniversity of Utah Research Foundation · 1996
- Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor288US 7,282,199 B2The Trustees of the University of Pennsylvania · 2007
- Biocompatible crosslinked polymers282US 7,009,034 B2Incept, LLC · 2006
- Preparation of functional human factor VIII in mammalian cells using methotrexate based selection276US 4,965,199 AGenentech, Inc. · 1990